Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01259
|
|||||
| Drug Name |
Amisulpride
|
|||||
| Synonyms |
4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-anisamid; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide; 4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide; 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-(ethylsulfonyl)-2-methoxybenzamide; 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide; Aminosultopride; Amisulpiride; Amisulprida; Amisulprida [INN-Spanish]; Amisulpride (INN); Amisulpride [INN]; Amisulpridum; Amisulpridum [INN-Latin]; DAN 2163; DAN-2163; Deniban; Deniban (TN); SL-91.1077; Socian; Solian; Solian (TN); Solian, Amisulpride
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Schizophrenia [ICD11: 6A20] | Approved | [1] | |||
| Dysthymia [ICD11: 6A72] | Approved | [1] | ||||
| Therapeutic Class |
Antipsychotic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H27N3O4S
|
|||||
| Canonical SMILES |
CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC
|
|||||
| InChI |
InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)
|
|||||
| InChIKey |
NTJOBXMMWNYJFB-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 53583-79-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 369.5 | Topological Polar Surface Area | 110 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
1.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
4426036
, 7978690
, 8151467
, 12013930
, 14852985
, 24890689
, 26719747
, 26719748
, 26753203
, 29221338
, 46386656
, 46386793
, 49681614
, 49875487
, 50105670
, 50740420
, 51091647
, 56311657
, 57321177
, 81041117
, 81092862
, 85208948
, 85789065
, 90341703
, 91746200
, 92308440
, 92721951
, 99437236
, 99443244
, 103527296
, 104299778
, 117878946
, 121361831
, 124658864
, 124757136
, 124801322
, 124891581
, 125001904
, 125163940
, 125312444
, 125356672
, 126592345
, 126618690
, 126660738
, 126665652
, 128751968
, 131324616
, 131342364
, 131480773
, 131849879
|
|||||
| ChEBI ID |
CHEBI:64045
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | AUSTRALIAN PRODUCT INFORMATION SOLIAN (AMISULPRIDE) TABLETS AND SOLUTION | |||||
| 2 | Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates. J Pharm Pharmacol. 2004 Aug;56(8):967-75. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.